Cargando…

Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model

BACKGROUND AND PURPOSE: Drug-induced prolongation of the QT interval can lead to torsade de pointes, a life-threatening ventricular arrhythmia. Finding appropriate assays from among the plethora of options available to predict reliably this serious adverse effect in humans remains a challenging issu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, X, Anderson, D L, Ross, S A, Lang, D G, Desai, B Z, Cooper, D C, Wheelan, P, McIntyre, M S, Bergquist, M L, MacKenzie, K I, Becherer, J D, Hashim, M A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442905/ https://www.ncbi.nlm.nih.gov/pubmed/18587422 http://dx.doi.org/10.1038/bjp.2008.267

Ejemplares similares

Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block
por: Tran, Phu N., et al.
Publicado: (2020)

hERG channel function: beyond long QT
por: Babcock, Joseph J, et al.
Publicado: (2013)

hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)

hERG1a N-terminal eag domain–containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: A possible mechanism for long QT syndrome
por: Trudeau, Matthew C., et al.
Publicado: (2011)

The electric heart of hERG
por: Islas, León D.
Publicado: (2013)

The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations
por: Orvos, Péter, et al.
Publicado: (2020)

Trigger vs. Substrate: Multi-Dimensional Modulation of QT-Prolongation Associated Arrhythmic Dynamics by a hERG Channel Activator
por: Colman, Michael A., et al.
Publicado: (2017)

Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy
por: LI, GUOLIANG, et al.
Publicado: (2016)

Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2019)

Pharmacological activation of the hERG K(+) channel for the management of the long QT syndrome: A review
por: El Harchi, Aziza, et al.
Publicado: (2022)

An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020)

Integrated Analysis of Drug-Induced Gene Expression Profiles Predicts Novel hERG Inhibitors
por: Babcock, Joseph J., et al.
Publicado: (2013)

Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
por: Zequn, Zheng, et al.
Publicado: (2021)

Pharmacometabolomic Approach to Predict QT Prolongation in Guinea Pigs
por: Park, Jeonghyeon, et al.
Publicado: (2013)

Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2018)

Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation
por: Aromolaran, Ademuyiwa S., et al.
Publicado: (2018)

The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)

Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles
por: Whittaker, Dominic G., et al.
Publicado: (2017)

In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome
por: Whittaker, Dominic G., et al.
Publicado: (2019)

Lipid regulation of hERG1 channel function
por: Miranda, Williams E., et al.
Publicado: (2021)

Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)

An Insight into the Potassium Currents of hERG and Their Simulation
por: Guidelli, Rolando
Publicado: (2023)

Transfer RNA-mediated restoration of potassium current and electrical correction in premature termination long-QT syndrome hERG mutants
por: Blomquist, Viggo G., et al.
Publicado: (2023)

Application of a systems pharmacology model for translational prediction of hERG‐mediated QTc prolongation
por: Gotta, Verena, et al.
Publicado: (2016)

Increased Vulnerability of Human Ventricle to Re-entrant Excitation in hERG-linked Variant 1 Short QT Syndrome
por: Adeniran, Ismail, et al.
Publicado: (2011)

Isoform-Specific Dominant-Negative Effects Associated with hERG1 G628S Mutation in Long QT Syndrome
por: Stump, Matthew R., et al.
Publicado: (2012)

Action Potential Clamp and Pharmacology of the Variant 1 Short QT Syndrome T618I hERG K(+) Channel
por: El Harchi, Aziza, et al.
Publicado: (2012)

Stereoselective Blockage of Quinidine and Quinine in the hERG Channel and the Effect of Their Rescue Potency on Drug-Induced hERG Trafficking Defect
por: Yan, Meng, et al.
Publicado: (2016)

hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome
por: McPate, M.J., et al.
Publicado: (2009)

Investigation of PAS and CNBH domain interactions in hERG channels and effects of long-QT syndrome-causing mutations with surface plasmon resonance
por: Soohoo, Stephanie M., et al.
Publicado: (2021)

The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models
por: Chioccioli Altadonna, Ginevra, et al.
Publicado: (2022)

Novel roles for hERG K(+) channels in cell proliferation and apoptosis
por: Jehle, J, et al.
Publicado: (2011)

A fingerprint pair analysis of hERG inhibition data
por: Springer, Clayton, et al.
Publicado: (2013)

Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups
por: Pillozzi, S, et al.
Publicado: (2014)

Natural products modulating the hERG channel: heartaches and hope
por: Kratz, Jadel M., et al.
Publicado: (2017)

Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
por: Ono, Makoto, et al.
Publicado: (2020)

Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
por: Durdagi, Serdar, et al.
Publicado: (2014)

Structure of the Cyclic Nucleotide-Binding Homology Domain of the hERG Channel and Its Insight into Type 2 Long QT Syndrome
por: Li, Yan, et al.
Publicado: (2016)

Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG ‘hotspot’ mutation
por: Du, Chunyun, et al.
Publicado: (2022)

Na(+) Permeation and Block of hERG Potassium Channels
por: Gang, Hongying, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_hc1v65egejlvrl0o0b04rf2ecf